{"predictions": [[{"text": "NG-nitro-L-arginine", "identifier": "C065583|C381333"}, {"text": "nitric-oxide synthase", "identifier": "E004227"}, {"text": "nitric oxide", "identifier": "A020890"}, {"text": "haloperidol", "identifier": "D009012"}, {"text": "catalepsy", "identifier": "D056485"}, {"text": "NG-nitro-L-arginine", "identifier": "C065583|C381333"}, {"text": "sub-chronic", "identifier": "D093523"}, {"text": "L-NOARG", "identifier": "C065583"}, {"text": "nitric-oxide", "identifier": "A02089"}], [{"text": "doxorubicin", "identifier": "D012133"}, {"text": "cardiotoxicity", "identifier": "D006511"}, {"text": "rat model", "identifier": "D010825"}, {"text": "cardiac magnetic resonance imaging", "identifier": "D036523"}, {"text": "Hannover Wistar rats", "identifier": "None"}, {"text": "doxorubicin", "identifier": "D012133"}, {"text": "subcellular degeneration", "identifier": "D003531"}, {"text": "mitochondrial changes", "identifier": "D007221"}, {"text": "cardiomyocyte degeneration", "identifier": "D010183"}, {"text": "hypertrophy", "identifier": "D006593"}], [{"text": "Levodopa", "identifier": "D002132"}, {"text": "Parkinson's disease", "identifier": "D001687"}, {"text": "dyskinesia", "identifier": "D003781"}, {"text": "multiethnic Malaysians", "identifier": "None"}, {"text": "chronic pulsatile levodopa therapy", "identifier": "None"}, {"text": "motor fluctuations", "identifier": "D006585"}, {"text": "UPDRS questionnaires", "identifier": "None"}, {"text": "predictors of dyskinesia", "identifier": "None"}, {"text": "cross-sectional study", "identifier": "D031111"}, {"text": "patients with PD", "identifier": "D001687"}, {"text": "uninterrupted levodopa therapy", "identifier": "None"}], [{"text": "ethambutol", "identifier": "D006685"}, {"text": "optic neuropathy", "identifier": "D006536"}, {"text": "tuberculosis", "identifier": "D001122"}, {"text": "lung", "identifier": "D001827"}, {"text": "lymph node", "identifier": "D003511"}, {"text": "Siriraj Hospital", "identifier": "None"}, {"text": "clinical characteristics", "identifier": "D006235"}, {"text": "visual outcome", "identifier": "D006235"}, {"text": "visual acuity", "identifier": "D010270"}, {"text": "initial visual acuity", "identifier": "D010270"}, {"text": "final visual acuity", "identifier": "D010270"}], [{"text": "Tetracycline", "identifier": "D012132"}, {"text": "rat", "identifier": "RN011614"}, {"text": "fatty liver", "identifier": "D006523"}, {"text": "dose-response relationships", "identifier": "D006865"}, {"text": "hepatic accumulation of triglyceride", "identifier": "None"}, {"text": "oleic acid", "identifier": "C052113"}, {"text": "intact rat", "identifier": "D010110"}, {"text": "isolated perfused liver", "identifier": "D010110"}, {"text": "male rat", "identifier": "RN016833"}, {"text": "female rat", "identifier": "RN016834"}], [{"text": "tobramycin", "identifier": "D012133"}, {"text": "carbenicillin", "identifier": "D012555"}, {"text": "neutropenia", "identifier": "D003490"}, {"text": "cancer patients", "identifier": "D011245"}, {"text": "myelosuppressive chemotherapy", "identifier": "D007596"}, {"text": "infections", "identifier": "D009893"}, {"text": "cure rate", "identifier": "D006256"}, {"text": "pneumonia", "identifier": "D001394"}, {"text": "gram-negative bacilli", "identifier": "D009428"}, {"text": "Klebsiella pneumoniae", "identifier": "D011126"}], [{"text": "cocaine", "identifier": "D011125"}, {"text": "recreational cocaine users", "identifier": "None"}, {"text": "facial expression recognition", "identifier": "D006888"}, {"text": "emotional facial expression", "identifier": "D006888"}, {"text": "happiness", "identifier": "D003711"}, {"text": "surprise", "identifier": "D003823"}, {"text": "sadness", "identifier": "D003824"}, {"text": "anger", "identifier": "D006232"}, {"text": "fear", "identifier": "D006233"}, {"text": "disgust", "identifier": "D003825"}, {"text": "psychopathology", "identifier": "D001871"}], [{"text": "Metronidazole", "identifier": "D004206"}, {"text": "encephalopathy", "identifier": "D001111"}, {"text": "neurological complications", "identifier": "D009047"}, {"text": "metronidazole", "identifier": "D004206"}, {"text": "prolonged metronidazole intake", "identifier": "None"}, {"text": "MRI", "identifier": "D006883"}, {"text": "brain", "identifier": "G04"}, {"text": "dentate nuclei", "identifier": "A053111"}, {"text": "cerebellum", "identifier": "A06.112.008.000"}, {"text": "splenium", "identifier": "A06.112.008.0"}], [{"text": "Parkinson's disease", "identifier": "D001687"}, {"text": "subthalamic nucleus", "identifier": "A053115"}, {"text": "high frequency stimulation", "identifier": "D035011"}, {"text": "advanced Parkinson's disease", "identifier": "D006515"}, {"text": "Hoehn and Yahr scale", "identifier": "D011123"}, {"text": "bradykinesia", "identifier": "D003688"}, {"text": "rigidity", "identifier": "D006886"}, {"text": "levodopa-induced dyskinesias", "identifier": "D006515"}, {"text": "Unified Parkinson's Disease Rating Scale", "identifier": "D010231"}], [{"text": "All-trans retinoic acid", "identifier": "C076613"}, {"text": "acute promyelocytic leukemia", "identifier": "C81658"}, {"text": "APL", "identifier": "C81658"}, {"text": "myositis", "identifier": "D011111"}, {"text": "inflammatory myositis", "identifier": "D011111"}, {"text": "skeletal muscle involvement", "identifier": "D011111"}, {"text": "adverse effects", "identifier": "D006246"}, {"text": "rare", "identifier": "R018120"}, {"text": "children", "identifier": "G029136"}, {"text": "recognition", "identifier": "D003137"}], [{"text": "Graves' disease", "identifier": "D001123"}, {"text": "propylthiouracil", "identifier": "D006585"}, {"text": "MPO-ANCA", "identifier": "D073113"}, {"text": "vasculitis", "identifier": "D006011"}, {"text": "Graves' disease patients", "identifier": "D001123"}, {"text": "PTU", "identifier": "D006585"}, {"text": "MPO-ANCA-positive vasculitis", "identifier": "D073113"}, {"text": "hyperthyroidism", "identifier": "D001225"}, {"text": "clinical manifestations", "identifier": "D006245"}, {"text": "appearance", "identifier": "D003595"}], [{"text": "Alendronate", "identifier": "D006955"}, {"text": "osteoporosis", "identifier": "D006552"}, {"text": "bone resorption", "identifier": "D006552"}, {"text": "bisphosphonates", "identifier": "D011113"}, {"text": "alendronate", "identifier": "D006955"}, {"text": "biphosphonate", "identifier": "D011113"}, {"text": "postmenopausal women", "identifier": "D004290"}, {"text": "side effects", "identifier": "D006211"}, {"text": "gastrointestinal", "identifier": "D006891"}, {"text": "musculoskeletal pain", "identifier": "D003512"}], [{"text": "Adriamycin", "identifier": "D012132"}, {"text": "spontaneously hypertensive rats", "identifier": "D010825"}, {"text": "losartan", "identifier": "D007312"}, {"text": "angiotensin II type-1 receptor blocker", "identifier": "D010233"}, {"text": "ADR nephropathy", "identifier": "D011111"}, {"text": "glomerulosclerosis", "identifier": "D010183"}, {"text": "proteinuria", "identifier": "D003822"}, {"text": "tubular atrophy", "identifier": "D011013"}, {"text": "interstitial fibrosis", "identifier": "D011013"}], [{"text": "Arginine vasopressin (AVP)", "identifier": "A125122"}, {"text": "Atrial natriuretic peptide (ANP)", "identifier": "A089330"}, {"text": "arterial blood pressure (MAP)", "identifier": "D093635"}, {"text": "heart rate (HR)", "identifier": "R031513"}, {"text": "normotensive rats (WKY)", "identifier": "R278115"}, {"text": "spontaneously hypertensive rats (SHR)", "identifier": "R278116"}, {"text": "arginine vasopressin", "identifier": "A125122"}, {"text": "atrial natriuretic peptide", "identifier": "A089330"}], [{"text": "Quetiapine", "identifier": "D010513"}, {"text": "schizo-affective disorder", "identifier": "D001315"}, {"text": "first-generation antipsychotics", "identifier": "D010175"}, {"text": "zuclopenthixol", "identifier": "D011111"}, {"text": "lithium", "identifier": "D006487"}, {"text": "serum lithium", "identifier": "D06H18"}, {"text": "agitation", "identifier": "D003531"}, {"text": "environmental explanation", "identifier": "D028531"}, {"text": "manic shift", "identifier": "D001123"}, {"text": "akathisia", "identifier": "D003531"}], [{"text": "disseminated necrotizing leukoencephalopathy", "identifier": "D010123|D011013"}, {"text": "acute lymphoblastic leukemia", "identifier": "D006595"}, {"text": "high-dose methotrexate", "identifier": "D011111"}, {"text": "magnetic resonance images", "identifier": "D007228"}, {"text": "white matter", "identifier": "D009323"}, {"text": "contrast enhancement", "identifier": "D028652"}, {"text": "necrosis", "identifier": "D001199"}, {"text": "myelination", "identifier": "D003596"}, {"text": "leukoencephalopathy", "identifier": "D01"}], [{"text": "pilocarpine", "identifier": "D006568"}, {"text": "temporal lobe epilepsy", "identifier": "D006568|D006567"}, {"text": "neuropathological sequelae", "identifier": "D003485"}, {"text": "gamma-aminobutyric acid (GABA)", "identifier": "D007198"}, {"text": "substantia nigra", "identifier": "D010120"}, {"text": "L-glutamic acid decarboxylase", "identifier": "D011113"}, {"text": "isoniazid", "identifier": "D011113"}, {"text": "SNR", "identifier": "D010120"}, {"text": "non-convulsant doses", "identifier": "None"}], [{"text": "Methamphetamine", "identifier": "C075842"}, {"text": "neurotoxic dose", "identifier": "D006934"}, {"text": "long-lasting depressive-like behaviour", "identifier": "D006588"}, {"text": "monoaminergic system", "identifier": "D010135"}, {"text": "methamphetamine", "identifier": "C075842"}, {"text": "disruption", "identifier": "D006233"}, {"text": "depressive symptoms", "identifier": "D009012"}, {"text": "drug withdrawal", "identifier": "D006233"}, {"text": "swimming speed", "identifier": "D003683"}, {"text": "escape latency", "identifier": "D006588"}], [{"text": "postoperative delirium", "identifier": "D001111"}, {"text": "population", "identifier": "D011022"}, {"text": "risk factors", "identifier": "D028227"}, {"text": "ICU", "identifier": "D091522"}, {"text": "elective major surgery", "identifier": "D009288"}, {"text": "confusion assessment method", "identifier": "D011881"}, {"text": "early postoperative delirium", "identifier": "D001111"}, {"text": "prevalence", "identifier": "D003510"}, {"text": "anesthetic drugs", "identifier": "D063423"}, {"text": "thiopentone", "identifier": "C001913"}, {"text": "propofol", "identifier": ""}], [{"text": "ecstasy", "identifier": "C176533"}, {"text": "dysfunctional overnight memory consolidation", "identifier": "None"}, {"text": "memory consolidation", "identifier": "D007200"}, {"text": "regular ecstasy users", "identifier": "None"}, {"text": "drug naive", "identifier": "D006286"}, {"text": "healthy controls", "identifier": "D003534"}, {"text": "word pairs", "identifier": "D003719"}, {"text": "sleep", "identifier": "D011390"}, {"text": "neurocognitive impairments", "identifier": "D009012"}, {"text": "associative interference", "identifier": "D006531"}, {"text": "frontostriatal neural circuitry", "identifier": "None"}], [{"text": "Dobutamine", "identifier": "D007113"}, {"text": "dobutamine stress echocardiography", "identifier": "D010235"}, {"text": "cocaine", "identifier": "C002292"}, {"text": "chest pain", "identifier": "R034.00"}, {"text": "STEMI", "identifier": "D001121"}, {"text": "ECG", "identifier": "R004.20"}, {"text": "tropinin I", "identifier": "D063112"}, {"text": "intensive diagnostic and treatment unit", "identifier": "R03.625.015.015.015.015"}, {"text": "intensive care unit", "identifier": "R03.625.015.015.0"}], [{"text": "antithrombotic drug", "identifier": "D006246"}, {"text": "cerebral microbleeds", "identifier": "D053613"}, {"text": "intracerebral hemorrhage", "identifier": "D009047"}, {"text": "ischemic stroke", "identifier": "D003455"}, {"text": "transient ischemic attack", "identifier": "D006251"}, {"text": "odds ratio", "identifier": "D011122"}, {"text": "cohorts", "identifier": "D003596"}, {"text": "follow-up studies", "identifier": "D006048"}, {"text": "stroke", "identifier": "D009830"}, {"text": "hemorrhage", "identifier": "D001745"}], [{"text": "suxamethonium", "identifier": "D006585"}, {"text": "post-suxamethonium pains", "identifier": "D011111"}, {"text": "Nigerian", "identifier": "D420133"}, {"text": "scoline pain", "identifier": "D011111"}, {"text": "Coxon", "identifier": "None"}, {"text": "prospective study", "identifier": "D006135"}, {"text": "total of 100 Nigerian patients", "identifier": "None"}, {"text": "out-patients", "identifier": "D003634"}, {"text": "in-patients", "identifier": "D003635"}, {"text": "fasciculations", "identifier": "D006585"}, {"text": "Fazadinium", "identifier": ""}], [{"text": "albuterol", "identifier": "D006081"}, {"text": "severe exacerbations of asthma", "identifier": "D001625"}, {"text": "adults", "identifier": "D006225"}, {"text": "continuously nebulized albuterol (CNA)", "identifier": "None"}, {"text": "intermittent albuterol (INA)", "identifier": "None"}, {"text": "cardiac dysrhythmias", "identifier": "D001831"}, {"text": "hypokalemia", "identifier": "D003522"}, {"text": "heart rates", "identifier": "D006552"}, {"text": "intubation", "identifier": "D003524"}, {"text": "mortality", "identifier": "D001185"}], [{"text": "Renal-transplant", "identifier": "D006518"}, {"text": "proteinuria", "identifier": "D003821"}, {"text": "everolimus", "identifier": "D010831"}, {"text": "mammalian target of rapamycin inhibitors", "identifier": "D010831"}, {"text": "mTOR-i", "identifier": "D010831"}, {"text": "AL amyloidosis", "identifier": "D001211"}, {"text": "monoclonal gammapathy", "identifier": "D006228"}, {"text": "undetermined significance", "identifier": "D053111"}, {"text": "histological evidence", "identifier": "D028027"}, {"text": "acute rejection", "identifier": "D0"}], [{"text": "Epinephrine", "identifier": "A010237"}, {"text": "bupivacaine", "identifier": "C017212"}, {"text": "dysrhythmias", "identifier": "D001827"}, {"text": "epinephrine", "identifier": "A010237"}, {"text": "bupivacaine", "identifier": "C017212"}, {"text": "conscious dogs", "identifier": "A076505"}, {"text": "healthy dogs", "identifier": "A061650"}, {"text": "myocardial infarction", "identifier": "D006327"}, {"text": "anesthetized dogs", "identifier": "A076405"}, {"text": "ventricular tachycardia", "identifier": "D006516"}], [{"text": "N-substituted piperazine derivative", "identifier": "None"}, {"text": "trans-2-amino-3-hydroxy-1, 2, 3, 4-tetrahydroanaphthalene", "identifier": "None"}, {"text": "N-(trans-3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-N-(3-oxo-3-phenyl-2-methylpropyl)-piperazine hydrochloride", "identifier": "None (Chemical name)"}, {"text": "P11", "identifier": "None"}, {"text": "anaesthesized cats", "identifier": "A07.512.315.250.250.250.300.300.300.300.300"}], [{"text": "Neuroleptic malignant syndrome", "identifier": "D006934"}, {"text": "risperidone", "identifier": "D010523"}, {"text": "levomepromazine", "identifier": "D007011"}, {"text": "chronic renal failure", "identifier": "D006592"}, {"text": "intestinal bleeding", "identifier": "D003811"}, {"text": "massive intestinal bleeding", "identifier": "D003811"}, {"text": "patient with CRF", "identifier": "D006592"}, {"text": "complication", "identifier": "D006214"}, {"text": "special caution", "identifier": "D011111"}], [{"text": "Hypercalcemia", "identifier": "D007196"}, {"text": "arrhythmia", "identifier": "D001111"}, {"text": "mood stabilizers", "identifier": "D010533"}, {"text": "lithium", "identifier": "D011121"}, {"text": "bipolar patient", "identifier": "D003531"}, {"text": "maintenance lithium therapy", "identifier": "None"}, {"text": "hypercalcemia", "identifier": "D007196"}, {"text": "severe bradyarrhythmia", "identifier": "D011111"}, {"text": "retrospective study", "identifier": "D009685"}, {"text": "bipolar patients", "identifier": "D003531"}], [{"text": "ibuprofen", "identifier": "D012132"}, {"text": "pulmonary hypertension", "identifier": "D007110"}, {"text": "very preterm infants", "identifier": "G71.019"}, {"text": "patent ductus arteriosus", "identifier": "D006891"}, {"text": "prophylactic treatment", "identifier": "D003825"}, {"text": "hypoxaemia", "identifier": "D003526"}, {"text": "echocardiography", "identifier": "D03.402.312"}, {"text": "inhaled nitric oxide therapy", "identifier": "D09.311.500.500.500"}, {"text": "preterm infants", "identifier": "G30.00"}], [{"text": "contrast medium", "identifier": "D012132"}, {"text": "nephrotoxicity", "identifier": "D010131"}, {"text": "renal dysfunction", "identifier": "D006527"}, {"text": "iodinated contrast medium", "identifier": "D012132"}, {"text": "renal angioplasty", "identifier": "D009311"}, {"text": "percutaneous coronary intervention", "identifier": "D006251"}, {"text": "creatinine", "identifier": "D007115"}, {"text": "patients", "identifier": "D003325"}, {"text": "interventional procedure", "identifier": "D003820"}, {"text": "benefit", "identifier": "D003506"}], [{"text": "aminoglycosides", "identifier": "D012132"}, {"text": "nephrotoxicity", "identifier": "D006235"}, {"text": "proximal tubular damage", "identifier": "D006528"}, {"text": "glomerular", "identifier": "D003719"}, {"text": "tubular dysfunction", "identifier": "D006528"}, {"text": "clinical trials", "identifier": "D002831"}, {"text": "seriously ill patients", "identifier": "D009296"}, {"text": "acute renal failure", "identifier": "D006525"}, {"text": "duration of therapy", "identifier": "D006561"}, {"text": "plasma aminoglycoside levels", "identifier": "D006561"}], [{"text": "Amiodarone", "identifier": "D006513"}, {"text": "torsade de pointes", "identifier": "D011113"}, {"text": "oral amiodarone therapy", "identifier": "None"}, {"text": "hypokalemia", "identifier": "D007111"}, {"text": "digoxin excess", "identifier": "D006583"}, {"text": "bladder irrigation", "identifier": "D006835"}, {"text": "proarrhythmia", "identifier": "D006583"}, {"text": "bradycardia", "identifier": "D006225"}, {"text": "vagal maneuver", "identifier": "D006235"}, {"text": "amiodarone-induced proarrhythmia", "identifier": "None"}], [{"text": "nicotine", "identifier": "D006352"}, {"text": "seizures", "identifier": "D009347"}, {"text": "hippocampal nicotinic receptors", "identifier": "None"}, {"text": "alpha-bungarotoxin", "identifier": "C014211"}, {"text": "mice", "identifier": "D025511"}, {"text": "classical F2 and backcross genetic design", "identifier": "None"}, {"text": "alpha-bungarotoxin binding", "identifier": "D006571"}, {"text": "dithiothreitol", "identifier": "C002125"}, {"text": "trypsin", "identifier": "C011122"}, {"text": "heat", "identifier": "D003596"}], [{"text": "Chronic hyperprolactinemia", "identifier": "D001113|D003533"}, {"text": "prolactin", "identifier": "D006537"}, {"text": "TIDA system", "identifier": "None"}, {"text": "haloperidol", "identifier": "D006585"}, {"text": "dopamine", "identifier": "D006893"}, {"text": "median eminence", "identifier": "A06.112.012.012.012.012"}, {"text": "norepinephrine", "identifier": "D011111"}, {"text": "serotonin", "identifier": "D011121"}, {"text": "5-hydroxyindoleacetic acid", "identifier": "D01112"}], [{"text": "Progesterone", "identifier": "D006595"}, {"text": "bupivacaine", "identifier": "C017313"}, {"text": "arrhythmogenicity", "identifier": "D006537"}, {"text": "pentobarbital", "identifier": "D010525"}, {"text": "rats", "identifier": "R01"}, {"text": "anesthetized rats", "identifier": "D010525"}, {"text": "beating rat heart myocyte cultures", "identifier": "None"}, {"text": "AD50", "identifier": "None"}, {"text": "progesterone HCl", "identifier": "None"}, {"text": "estradiol", "identifier": "D013233"}, {"text": "epinephrine", "identifier": "D011111"}], [{"text": "Bepridil hydrochloride", "identifier": "D011111"}, {"text": "atrial fibrillation", "identifier": "D001102"}, {"text": "atrial flutter", "identifier": "D001103"}, {"text": "torsade de pointes", "identifier": "D006934"}, {"text": "left ventricular ejection fraction", "identifier": "D010132"}, {"text": "atrial dimension", "identifier": "D010133"}, {"text": "serum potassium concentration", "identifier": "D003581"}, {"text": "ECG", "identifier": "D001101"}, {"text": "hypokalemia", "identifier": "D003572"}, {"text": "heart rate", "identifier": "D003561"}], [{"text": "Rifampicin", "identifier": "D011111"}, {"text": "segmental necrotizing glomerulonephritis", "identifier": "D011133"}, {"text": "glomerulonephritis", "identifier": "D006585"}, {"text": "staphylococcal endocarditis", "identifier": "D006533"}, {"text": "acute renal failure", "identifier": "D006561"}, {"text": "tuberculosis", "identifier": "D001122"}, {"text": "IE", "identifier": "D006533"}, {"text": "Staphylococcal infections", "identifier": "D006533"}, {"text": "renal failure", "identifier": "D006561"}], [{"text": "methamphetamine", "identifier": "C076492"}, {"text": "psychosis", "identifier": "D009123"}, {"text": "methamphetamine-dependent patients", "identifier": "D009123.525.500.500.505.505.535"}, {"text": "risk", "identifier": "D006249"}, {"text": "DSM-IV", "identifier": "D011121"}, {"text": "teaching hospital", "identifier": "D09.312.350.350"}, {"text": "drug rehabilitation center", "identifier": "D009615"}, {"text": "patients", "identifier": "D003630"}, {"text": "mini international neuropsychiatric interview", "identifier": ""}], [{"text": "Niacin extended-release/lovastatin", "identifier": "D011111|D010525"}, {"text": "primary hypercholesterolemia", "identifier": "D001121"}, {"text": "mixed dyslipidemia", "identifier": "D006513"}, {"text": "Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT)", "identifier": "None"}, {"text": "niacin extended-release", "identifier": "D011111"}, {"text": "lovastatin", "identifier": "D010525"}, {"text": "dyslipidemia", "identifier": "D006513"}, {"text": "drug intervention", "identifier": "D006246"}, {"text": "bedtime", "identifier": "D0635"}], [{"text": "5-Fluorouracil", "identifier": "D012136"}, {"text": "cardiotoxicity", "identifier": "D006537"}, {"text": "alpha-fluoro-beta-alanine", "identifier": "None"}, {"text": "FBAL", "identifier": "None"}, {"text": "5-FU", "identifier": "D012136"}, {"text": "malignancies", "identifier": "D009033"}, {"text": "unresectable colon cancer", "identifier": "D011111"}, {"text": "liver", "identifier": "D009822"}, {"text": "lung", "identifier": "D013182"}, {"text": "70-year-old man", "identifier": "D006524"}, {"text": "precordial pain", "identifier": "D0069"}], [{"text": "bortezomib", "identifier": "D010835"}, {"text": "thalidomide", "identifier": "D012722"}, {"text": "dexamethasone", "identifier": "D093562"}, {"text": "VTD", "identifier": "None"}, {"text": "multiple myeloma", "identifier": "D009223"}, {"text": "autologous stem cell transplantation", "identifier": "D006246"}, {"text": "consolidation therapy", "identifier": "D056486"}, {"text": "bortezomib", "identifier": "D010835"}, {"text": "thalidomide", "identifier": "D012722"}, {"text": "dexamethasone", "identifier": "D093562"}], [{"text": "Glyceryl trinitrate", "identifier": "C002351"}, {"text": "diclofenac", "identifier": "D012732"}, {"text": "primary dysmenorrhea", "identifier": "D001111"}, {"text": "prostaglandins", "identifier": "A048190"}, {"text": "nitric oxide", "identifier": "A003833"}, {"text": "NO", "identifier": "A003833"}, {"text": "hypersecretion", "identifier": "D003827"}, {"text": "endometrial", "identifier": "D006546"}, {"text": "uterine contractility", "identifier": "D006833"}, {"text": "non-steroidal anti-inflammatory drugs", "identifier": "D013453"}], [{"text": "Metallothionein", "identifier": "D011128"}, {"text": "ZnSO4", "identifier": "C002193"}, {"text": "carmustine", "identifier": "D011133 (BCNU)"}, {"text": "hippocampus", "identifier": "D009662"}, {"text": "cognitive functions", "identifier": "D003111"}, {"text": "learning", "identifier": "D003111"}, {"text": "short-term memory", "identifier": "D006547"}, {"text": "glutathione reductase", "identifier": "E004225"}, {"text": "reduced glutathione", "identifier": "C002225"}, {"text": "tumor necrosis factor-alpha", "identifier": "D013"}], [{"text": "Chlorhexidine diphosphanilate", "identifier": "None"}, {"text": "topical agent", "identifier": "D006225"}, {"text": "burns", "identifier": "D003490"}, {"text": "antimicrobial agents", "identifier": "D006218"}, {"text": "chlorhexidine phosphanilate", "identifier": "None"}, {"text": "burn patients", "identifier": "D003490"}, {"text": "infection", "identifier": "D001122"}, {"text": "mortality", "identifier": "D003577"}, {"text": "clinical trials", "identifier": "D002831"}, {"text": "pain", "identifier": "D003507"}, {"text": "analogue scale", "identifier": "None"}], [{"text": "Aspirin", "identifier": "D006805"}, {"text": "coronary heart disease", "identifier": "D001122"}, {"text": "cerebrovascular disease", "identifier": "D009042"}, {"text": "US Preventive Services Task Force", "identifier": "None"}, {"text": "cardiovascular events", "identifier": "D001122"}, {"text": "myocardial infarctions", "identifier": "D001122"}, {"text": "strokes", "identifier": "D003490"}, {"text": "death", "identifier": "D011348"}, {"text": "coronary heart disease", "identifier": "D001122"}, {"text": "cerebrovascular disease", "identifier": "D009042"}], [{"text": "acute kidney injury", "identifier": "D006512|D003556"}, {"text": "hospitalized", "identifier": "D003630"}, {"text": "Intensive Care Unit", "identifier": "D091122"}, {"text": "mortality", "identifier": "D011027"}, {"text": "hospital length of stay", "identifier": "D027625"}, {"text": "costs", "identifier": "D027587"}, {"text": "standard operating procedures", "identifier": "D011028"}, {"text": "antibiotics", "identifier": "D006205"}, {"text": "nephrotoxic", "identifier": "D006512"}, {"text": "vancomycin", "identifier": "D006573"}], [{"text": "Carbetocin", "identifier": "D011113"}, {"text": "maximum tolerated dose (MTD)", "identifier": "D006028"}, {"text": "intramuscular", "identifier": "D063515"}, {"text": "vaginal delivery", "identifier": "D006255"}, {"text": "normal vaginal birth", "identifier": "D006255"}, {"text": "healthy women", "identifier": "D003531"}, {"text": "singleton pregnancies", "identifier": "D010830"}, {"text": "term", "identifier": "D006235"}, {"text": "continual reassessment method (CRM)", "identifier": "D011831"}, {"text": "adverse events", "identifier": "D003485"}], [{"text": "anxiety", "identifier": "D009246"}, {"text": "postoperative", "identifier": "D009533"}, {"text": "droperidol", "identifier": "D006513"}, {"text": "patient-controlled analgesia", "identifier": "D011111"}, {"text": "diamorphine", "identifier": "D012172"}, {"text": "psychological disturbance", "identifier": "D009246"}, {"text": "dopaminergic antiemetics", "identifier": "D010935"}, {"text": "extrapyramidal side effects", "identifier": "D006513"}, {"text": "subtle manifestations", "identifier": "D053425"}, {"text": "overlooked", "identifier": "D003512"}], [{"text": "Methyldopa", "identifier": "D008750|D010133|D010134"}, {"text": "hemolytic anemia", "identifier": "D001193"}, {"text": "antihypertensive medication", "identifier": "D003137"}, {"text": "Aldomet", "identifier": "D010133"}, {"text": "trauma admission", "identifier": "D009351"}, {"text": "Coombs' test", "identifier": "D003581"}, {"text": "polyspecific anti-human globulin", "identifier": "D011111"}, {"text": "monospecific IgG reagents", "identifier": "D011111"}, {"text": "warm reacting autoantibody", "identifier": ""}], [{"text": "Botulinum toxin", "identifier": "A011111|B007143"}, {"text": "Botox", "identifier": "A011111|B007143"}, {"text": "adductor spasmodic dysphonia", "identifier": "D011111"}, {"text": "ADSD", "identifier": "D011111"}, {"text": "breathiness", "identifier": "D006985"}, {"text": "throat pain", "identifier": "D003511"}, {"text": "difficulty swallowing", "identifier": "D011133"}, {"text": "botulinum toxin injections", "identifier": "A011111|B007143"}, {"text": "thyroarytenoid muscles", "identifier": "A08"}], [{"text": "Gentamicin", "identifier": "D011111"}, {"text": "nephropathy", "identifier": "D006205"}, {"text": "Na/K-ATPase", "identifier": "D007122"}, {"text": "NHE3", "identifier": "D010128"}, {"text": "NBC1", "identifier": "D010130"}, {"text": "AQP1", "identifier": "D010131"}, {"text": "OAT", "identifier": "D007130"}, {"text": "creatinine clearance", "identifier": "D003527"}, {"text": "plasma creatinine", "identifier": "D003528"}, {"text": "fractional excretion of sodium", "identifier": "D007133"}], [{"text": "oxitropium bromide", "identifier": "C012235"}, {"text": "nocturnal asthma", "identifier": "D006783"}, {"text": "placebo-controlled", "identifier": "D003111"}, {"text": "double-blind study", "identifier": "D003111"}, {"text": "oxitropium bromide", "identifier": "C012235"}, {"text": "600 micrograms", "identifier": "None"}, {"text": "400 micrograms", "identifier": "None"}, {"text": "theophylline", "identifier": "D007112"}, {"text": "slow-release theophylline", "identifier": "None"}, {"text": "nocturnal asthma", "identifier": "D006783"}], [{"text": "Pethidine", "identifier": "D006206"}, {"text": "opioid", "identifier": "D011111"}, {"text": "opioid-receptors", "identifier": "D010135"}, {"text": "norpethidine", "identifier": "D011111"}, {"text": "nausea", "identifier": "D007290"}, {"text": "vomiting", "identifier": "D003720"}, {"text": "hypotension", "identifier": "D007022"}, {"text": "renal function", "identifier": "D006548"}, {"text": "liver function", "identifier": "D006507"}, {"text": "long-term pain control", "identifier": "D006246"}], [{"text": "Biperiden", "identifier": "D007112"}, {"text": "bradycardia", "identifier": "D006512"}, {"text": "38-year-old", "identifier": "D006870"}, {"text": "male", "identifier": "M000045"}, {"text": "severe postzosteric trigeminal neuralgia", "identifier": "D006516"}, {"text": "intravenous application", "identifier": "D003635"}, {"text": "10 mg biperiden lactate", "identifier": "None"}, {"text": "paradoxical reaction", "identifier": "D006934"}, {"text": "dysarthria", "identifier": "D003531"}, {"text": "dysphagia", "identifier": "D003528"}], [{"text": "Penicillamine", "identifier": "D011111"}, {"text": "lichenoid dermatitis", "identifier": "D048333"}, {"text": "Wilson's disease", "identifier": "D007513"}, {"text": "hepatic presentation", "identifier": "D006523"}, {"text": "anxiety", "identifier": "D009835"}, {"text": "SPECT", "identifier": "D006935"}, {"text": "99mTc-ECD", "identifier": "D011115"}, {"text": "frontal lobes", "identifier": "D003526"}, {"text": "copper metabolism", "identifier": "D011110"}, {"text": "copper accumulation", "identifier": "D011110"}], [{"text": "Histamine antagonists", "identifier": "D006815"}, {"text": "d-tubocurarine", "identifier": "D011111"}, {"text": "cardiac surgical patients", "identifier": "D009593"}, {"text": "hemodynamic effects", "identifier": "D006547"}, {"text": "histamine", "identifier": "H4142"}, {"text": "H1-histamine antagonists", "identifier": "D006815|C001933"}, {"text": "H2-histamine antagonists", "identifier": "D006815|C001934"}, {"text": "cimetidine", "identifier": "D003521"}, {"text": "chlorpheniramine", "identifier": "C000213"}], [{"text": "lithium", "identifier": "D006555"}, {"text": "manic depression", "identifier": "D009047"}, {"text": "hyperosmolar nonketotic coma", "identifier": "D053011"}, {"text": "nephrogenic diabetes insipidus", "identifier": "D006883"}, {"text": "polyuria", "identifier": "D003811"}, {"text": "polydipsia", "identifier": "D003812"}, {"text": "hyperglycaemia", "identifier": "D003815"}, {"text": "normal blood glucose concentrations", "identifier": "D003815"}, {"text": "water deprivation testing", "identifier": "D003821"}, {"text": "type 2 diabetes", "identifier": "D02813"}], [{"text": "Exercise", "identifier": "D003531"}, {"text": "isoproterenol", "identifier": "D008312"}, {"text": "myocardial infarction", "identifier": "D006325"}, {"text": "male rats", "identifier": "D010826"}, {"text": "treadmill", "identifier": "D011113"}, {"text": "mortality", "identifier": "D011022"}, {"text": "CPK activity", "identifier": "D068933"}, {"text": "severity", "identifier": "D028557"}, {"text": "infarction", "identifier": "D006325"}, {"text": "lesions", "identifier": "D028557"}, {"text": "heart weight", "identifier": "D0065"}], [{"text": "doxorubicin", "identifier": "D012132"}, {"text": "monohydroxyethylrutoside", "identifier": "None"}, {"text": "cardiotoxicity", "identifier": "D006537"}, {"text": "anthracyclin", "identifier": "D011135"}, {"text": "free radicals", "identifier": "D003595"}, {"text": "reactive oxygen species", "identifier": "D003595"}, {"text": "cardiac myocytes", "identifier": "D003613"}, {"text": "semisynthetic flavonoid", "identifier": "None"}, {"text": "monoHER", "identifier": "None"}, {"text": "BALB/c mice", "identifier": "D011006"}, {"text": "saline", "identifier": "D0616"}], [{"text": "Levodopa", "identifier": "D002706"}, {"text": "Parkinson's disease", "identifier": "D001223"}, {"text": "HOMER1", "identifier": "Q15212"}, {"text": "homer1", "identifier": "Q15212"}, {"text": "glutamate transmission", "identifier": "D007211"}, {"text": "motor fluctuations", "identifier": "D006588"}, {"text": "dyskinesia", "identifier": "D003711"}, {"text": "visual hallucinations", "identifier": "D006585"}, {"text": "rs4704559", "identifier": "None"}, {"text": "rs10942891", "identifier": "None"}], [{"text": "Levobupivacaine", "identifier": "D007115"}, {"text": "central nervous system", "identifier": "D003664"}, {"text": "toxicity", "identifier": "D003420"}, {"text": "local anesthetics", "identifier": "D06A51"}, {"text": "grand mal seizures", "identifier": "D009346"}, {"text": "lumbar plexus block", "identifier": "D052313"}, {"text": "posterior approach", "identifier": "D011111"}, {"text": "elective orthopedic surgery", "identifier": "D009625"}, {"text": "lower limb", "identifier": "D003526"}, {"text": "beta-adrenergic antagonist medications", "identifier": "D00611"}], [{"text": "hormones", "identifier": "D000695"}, {"text": "breast cancer", "identifier": "C153200"}, {"text": "hormonal replacement therapy", "identifier": "D006225"}, {"text": "menopausal women", "identifier": "Women's Health Issues/menopause"}, {"text": "surgical menopause", "identifier": "D006225/surgical menopause"}, {"text": "mean age", "identifier": "D006870"}, {"text": "progestins", "identifier": "D006333"}, {"text": "estrogenic stimulation", "identifier": "D003536"}, {"text": "mammary", "identifier": "D009866"}, {"text": "endometrial", "identifier": "D006214"}], [{"text": "S-312-d", "identifier": "None"}, {"text": "S-312", "identifier": "None"}, {"text": "S-312-l", "identifier": "None"}, {"text": "dihydrothienopyridine", "identifier": "Chemical class not specified"}, {"text": "calcium antagonist", "identifier": "C020315"}, {"text": "DBA/2 mice", "identifier": "A026320"}, {"text": "audiogenic tonic convulsions", "identifier": "A082110"}, {"text": "ED50", "identifier": "D011111"}, {"text": "p.o.", "identifier": "D062952"}, {"text": "flunarizine", "identifier": "D006525"}], [{"text": "Amiodarone", "identifier": "D006513"}, {"text": "myxoedema coma", "identifier": "D001111"}, {"text": "bradycardia", "identifier": "D009011"}, {"text": "hypothermia", "identifier": "D003522"}, {"text": "respiratory failure", "identifier": "D021515"}, {"text": "atrial fibrillation", "identifier": "D001103"}, {"text": "thyroid-stimulating hormone", "identifier": "D007139"}, {"text": "free thyroxine", "identifier": "D007139"}, {"text": "levothyroxine", "identifier": "D006555"}, {"text": "intensive care unit", "identifier": "D09351"}], [{"text": "propranolol", "identifier": "D002217"}, {"text": "B 24/76", "identifier": "None"}, {"text": "isoproterenol", "identifier": "D003115"}, {"text": "heart hypertrophy", "identifier": "D006523"}, {"text": "rat", "identifier": "D010860"}, {"text": "blood pressure", "identifier": "D003829"}, {"text": "ornithine decarboxylase", "identifier": "D011331"}, {"text": "myosin isoenzyme", "identifier": "D011112"}, {"text": "beta-receptor blocker", "identifier": "D006935"}, {"text": "beta 1-adrenoceptor", "identifier": "D010121"}], [{"text": "epirubicin", "identifier": "D012112"}, {"text": "non-Hodgkin lymphoma", "identifier": "C8540"}, {"text": "echocardiography", "identifier": "E07-012"}, {"text": "speckle tracking echocardiography", "identifier": "None"}, {"text": "high-sensitive cardiac troponin T", "identifier": "D07.311.512.312.500.500.500.300.200.200.200.200.200.200.200.200.200.200.200.200.200.200.200.200.200.200"}], [{"text": "Delirium", "identifier": "D001211"}, {"text": "fluoxetine", "identifier": "D007113"}, {"text": "selective serotonin reuptake inhibitors", "identifier": "D010825"}, {"text": "tricyclic antidepressants", "identifier": "D011113"}, {"text": "serum concentrations", "identifier": "D062633"}, {"text": "central nervous system side effects", "identifier": "D003717"}, {"text": "elderly patients", "identifier": "G061331"}, {"text": "citalopram", "identifier": "D007113"}, {"text": "somnolence", "identifier": "D003521"}, {"text": "movement difficulties", "identifier": "D003311"}], [{"text": "Syndrome of inappropriate secretion of antidiuretic hormone", "identifier": "D007111"}, {"text": "vincristine", "identifier": "D012133"}, {"text": "antidiuretic hormone", "identifier": "A060220"}, {"text": "hyponatremia", "identifier": "D007132"}, {"text": "multiple myeloma", "identifier": "D001265"}, {"text": "refractory", "identifier": "D006211"}, {"text": "doxorubicin", "identifier": "D012153"}, {"text": "dexamethasone", "identifier": "D012167"}, {"text": "intravenous infusion", "identifier": "D042011"}], [{"text": "acute renal failure", "identifier": "D006525"}, {"text": "prolonged intake", "identifier": "D006561"}, {"text": "slimming pills", "identifier": "D009588"}, {"text": "anthraquinones", "identifier": "C013113"}, {"text": "Rhizoma Rhei", "identifier": "D011111"}, {"text": "rhubarb", "identifier": "D011111"}, {"text": "anthraquinone derivatives", "identifier": "None"}, {"text": "nephropathy", "identifier": "D006205"}, {"text": "Chinese herbal medicine", "identifier": "D011126"}, {"text": "phytotherapy", "identifier": "D011126"}], [{"text": "5-fluorouracil", "identifier": "D012133"}, {"text": "transient hyperammonemic encephalopathy", "identifier": "D006885|D006886"}, {"text": "cancer patients", "identifier": "D003596"}, {"text": "dehydration", "identifier": "D003717"}, {"text": "infection", "identifier": "D003480"}, {"text": "5-fluorouracil", "identifier": "D012133"}, {"text": "hyperammonemic encephalopathy", "identifier": "D006885|D006886"}, {"text": "plasma ammonium", "identifier": "D007111"}, {"text": "azotemia", "identifier": "D00"}], [{"text": "17alpha-ethinylestradiol", "identifier": "D011123"}, {"text": "bile salt", "identifier": "D006352"}, {"text": "neutral pathway", "identifier": "None"}, {"text": "acidic pathway", "identifier": "None"}, {"text": "17alpha-ethinylestradiol", "identifier": "D011123"}, {"text": "intact enterohepatic circulation", "identifier": "D010133"}, {"text": "long-term bile diversion", "identifier": "D006835"}, {"text": "bile salt pool composition", "identifier": "D006352"}, {"text": "cholate", "identifier": "D007115"}, {"text": "chenodeoxycholate", "identifier": "D007116"}], [{"text": "Convulsion", "identifier": "D001111"}, {"text": "intravenous fluorescein", "identifier": "C014512"}, {"text": "fundus angiography", "identifier": "D006535"}, {"text": "tonic-clonic seizures", "identifier": "D001111"}, {"text": "fluorescein", "identifier": "C014512"}, {"text": "adverse reaction", "identifier": "D003440"}, {"text": "re-exposure", "identifier": "D003536"}], [{"text": "Human corticotropin-releasing hormone (hCRH)", "identifier": "A027122|A089315"}, {"text": "Thyrotropin-releasing hormone (TRH)", "identifier": "A027122|A089315"}, {"text": "ventilation", "identifier": "D006588"}, {"text": "humans", "identifier": "G001335"}, {"text": "placebo-controlled", "identifier": "D003111"}, {"text": "single-blind study", "identifier": "D003111"}, {"text": "CO2-rebreathing tests", "identifier": "D006588"}, {"text": "0.9% NaCl", "identifier": "C052201"}], [{"text": "1,3-Butadiene", "identifier": "C062193"}, {"text": "chronic myeloid leukemia", "identifier": "C41400"}, {"text": "CML", "identifier": "C41400"}, {"text": "ionizing radiation", "identifier": "D003537"}, {"text": "Philadelphia chromosome", "identifier": "D010113"}, {"text": "translocation", "identifier": "D003536"}, {"text": "human myeloid cell line", "identifier": "D010633"}, {"text": "positive control", "identifier": "D006"}], [{"text": "Hyponatremia", "identifier": "D007132"}, {"text": "syndrome of inappropriate secretion of anti-diuretic hormone (SIADH)", "identifier": "D006937"}, {"text": "Vincristine", "identifier": "D006555"}, {"text": "leukemia", "identifier": "D001265"}, {"text": "lymphoma", "identifier": "D001181"}, {"text": "Asians", "identifier": "A024220"}, {"text": "hyponatremia and/or SIADH", "identifier": "D007132|D006937"}, {"text": "reporting rate", "identifier": "D006836"}, {"text": "treated patients", "identifier": "D003725"}], [{"text": "Neurocognitive", "identifier": "D006547"}, {"text": "neuroradiologic", "identifier": "D036113"}, {"text": "central nervous system", "identifier": "D003526"}, {"text": "children", "identifier": "G029136"}, {"text": "Pediatric Oncology Group", "identifier": "None"}, {"text": "P9605", "identifier": "None"}, {"text": "P9201", "identifier": "None"}, {"text": "acute lymphoblastic leukemia", "identifier": "D009588"}, {"text": "standard risk", "identifier": "None"}, {"text": "intensive consolidation", "identifier": "None"}, {"text": "intrathecal", "identifier": "D010211"}], [{"text": "Crocin", "identifier": "D011111"}, {"text": "diazinon", "identifier": "D011133"}, {"text": "organophosphorus insecticides", "identifier": "D011133"}, {"text": "lipid metabolism", "identifier": "D010871"}, {"text": "cholesterol", "identifier": "C000223"}, {"text": "triglyceride", "identifier": "C002234"}, {"text": "LDL", "identifier": "D003711"}, {"text": "low-density lipoprotein receptor", "identifier": "D007113"}, {"text": "Extracellular signal-regulated kinase", "identifier": "D010290"}, {"text": "ERK", "identifier": "D0102"}], [{"text": "olanzapine", "identifier": "D010525"}, {"text": "acute bipolar mania", "identifier": "D009093"}, {"text": "DSM-IV", "identifier": "D001232"}, {"text": "Young-Mania Rating Scale (Y-MRS)", "identifier": "None"}, {"text": "Olanzipine HGGW Study Group", "identifier": "None"}, {"text": "bipolar disorder", "identifier": "D009093"}, {"text": "manic", "identifier": "D009093"}, {"text": "mixed", "identifier": "D009093"}, {"text": "DSM-IV diagnosis", "identifier": "D001232"}, {"text": "randomized", "identifier": "D000635"}], [{"text": "Levetiracetam", "identifier": "D011113"}, {"text": "phenobarbital", "identifier": "D011111"}, {"text": "cats", "identifier": "G010131"}, {"text": "epilepsy", "identifier": "D007205"}, {"text": "idiopathic epilepsy", "identifier": "D007205"}, {"text": "pharmacokinetics", "identifier": "D003595"}, {"text": "efficacy", "identifier": "D006246"}, {"text": "tolerability", "identifier": "D006246"}, {"text": "seizure frequency", "identifier": "D006875"}, {"text": "seizures", "identifier": "D006875"}], [{"text": "trazodone", "identifier": "D007215"}, {"text": "5-hydroxytryptamine", "identifier": "A039859"}, {"text": "5-HT", "identifier": "A039859"}, {"text": "5-HT 2A receptors", "identifier": "D010123"}, {"text": "5-HT 2C receptors", "identifier": "D010125"}, {"text": "dopaminergic neurotransmission", "identifier": "D003011"}, {"text": "dexamphetamine", "identifier": "C011113"}, {"text": "apomorphine", "identifier": "C011195"}, {"text": "haloperidol", "identifier": "D009285"}, {"text": "ergometrine", "identifier": "C"}], [{"text": "Asterixis", "identifier": "D003531"}, {"text": "carbamazepine", "identifier": "D007112"}, {"text": "psychopharmacologic agents", "identifier": "D011113"}, {"text": "neurotoxicity", "identifier": "D006547"}, {"text": "lithium", "identifier": "D006555"}, {"text": "clozapine", "identifier": "D006534"}, {"text": "CBZ", "identifier": "D007112"}, {"text": "psychotropic drugs", "identifier": "D011113"}, {"text": "combination therapy", "identifier": "D006934"}, {"text": "dosage", "identifier": "D011110"}], [{"text": "Non-steroidal anti-inflammatory drugs (NSAIDs)", "identifier": "D012716"}, {"text": "acute interstitial nephritis (ATIN)", "identifier": "D006533"}, {"text": "acute renal failure", "identifier": "D001223"}, {"text": "immune complex-mediated tubulo-interstitial injury", "identifier": "D056486"}, {"text": "aspirin", "identifier": "D006800"}, {"text": "ibuprofen", "identifier": "D012835"}, {"text": "aortic valve surgery", "identifier": "D006525"}, {"text": "blood urea nitrogen (BUN)", "identifier": "D003425"}, {"text": "creatinine", "identifier": ""}], [{"text": "Fluoxetine", "identifier": "D007214"}, {"text": "5-fluorouracil", "identifier": "D012133"}, {"text": "chemotherapy", "identifier": "D011111"}, {"text": "5-FU", "identifier": "D012133"}, {"text": "cancer patients", "identifier": "D009575"}, {"text": "systemic adjuvant chemotherapy", "identifier": "D006836"}, {"text": "blood-brain barrier", "identifier": "D006547"}, {"text": "neurogenesis", "identifier": "D003491"}, {"text": "adult brain", "identifier": "D003526"}, {"text": "hippocampal dependent neurogenesis", "identifier": "D003491"}], [{"text": "Pilsicainide", "identifier": "D006935"}, {"text": "sudden cardiac death", "identifier": "D001235"}, {"text": "torsades de pointes", "identifier": "D006523"}, {"text": "paroxysmal atrial fibrillation", "identifier": "D001113"}, {"text": "sinus rhythm", "identifier": "D006286"}, {"text": "Holter electrocardiogram", "identifier": "D006537"}, {"text": "gastrointestinal tract", "identifier": "G026231"}, {"text": "renal function", "identifier": "D006547"}, {"text": "plasma concentration", "identifier": "D003596"}, {"text": "class IC drugs", "identifier": "D010215"}], [{"text": "Branch retinal vein occlusion", "identifier": "D006553"}, {"text": "fluoxetine", "identifier": "D011112"}, {"text": "selective serotonin reuptake inhibitor", "identifier": "D010826"}, {"text": "hypertension", "identifier": "D007022"}, {"text": "ophthalmologists", "identifier": "D011122"}, {"text": "secondary hypertension", "identifier": "D006510"}, {"text": "fluoxetine-induced hypertension", "identifier": "None"}, {"text": "branch retinal vein occlusion", "identifier": "D006553"}, {"text": "fluoxetine", "identifier": "D011112"}, {"text": "ophthalmology", "identifier": "D011122"}], [{"text": "Amiodarone", "identifier": "D006513"}, {"text": "anti-arrhythmic drug", "identifier": "D006513"}, {"text": "valvular heart disease", "identifier": "D006586"}, {"text": "lung mass", "identifier": "D029113"}, {"text": "proteinuria", "identifier": "D003827"}, {"text": "CT", "identifier": "D032945"}, {"text": "positron emission tomography", "identifier": "D006982"}, {"text": "lymphoplasmacytic infiltrates", "identifier": "D055123"}, {"text": "foamy macrophages", "identifier": "D073813"}, {"text": "myelinoid bodies", "identifier": "D003591"}], [{"text": "vincristine sulfate", "identifier": "D012132"}, {"text": "Pseudomonas aeruginosa", "identifier": "D011127"}, {"text": "rhesus monkeys", "identifier": "D011112"}, {"text": "acute illness", "identifier": "D001311"}, {"text": "spontaneous recovery", "identifier": "D006231"}, {"text": "leukocytosis", "identifier": "D003531"}, {"text": "blood cultures", "identifier": "D035111"}, {"text": "leukopenia", "identifier": "D003531"}, {"text": "pyocin type 6 Pseudomonas", "identifier": "None"}, {"text": "severe Pseudomonas sepsis", "identifier": "D0064"}], [{"text": "remoxipride", "identifier": "D011111"}, {"text": "apoptosis", "identifier": "D011354"}, {"text": "HL60", "identifier": "D011113"}, {"text": "CD34+/CD19-", "identifier": "D010526"}, {"text": "human bone marrow progenitor cells", "identifier": "D010526"}, {"text": "acquired aplastic anemia", "identifier": "D001111"}, {"text": "NCQ436", "identifier": "None"}, {"text": "NCQ344", "identifier": "None"}, {"text": "NCR181", "identifier": "None"}, {"text": "FLA873", "identifier": "None"}, {"text": "FLA797", "identifier": "None"}], [{"text": "ACC-9653", "identifier": "None"}, {"text": "phenytoin", "identifier": "D009047"}, {"text": "prodrug", "identifier": "D011113"}, {"text": "3-hydroxymethyl-5,5-diphenylhydantoin", "identifier": "None"}, {"text": "anticonvulsant", "identifier": "D010115"}, {"text": "seizures", "identifier": "D007206"}, {"text": "maximal electroshock", "identifier": "D011128"}, {"text": "mice", "identifier": "D101011"}, {"text": "oral", "identifier": "D065180"}, {"text": "i.v.", "identifier": "D062782"}], [{"text": "Cisplatin", "identifier": "D012106"}, {"text": "acute kidney injury", "identifier": "D006511"}, {"text": "renal function", "identifier": "D006511"}, {"text": "creatinine", "identifier": "D003528"}, {"text": "urea", "identifier": "D007113"}, {"text": "acute tubular necrosis", "identifier": "D006511"}, {"text": "IL-1b", "identifier": "D011331"}, {"text": "TNF-a", "identifier": "D011332"}, {"text": "kinin B2 receptor", "identifier": "D010113"}, {"text": "deletion", "identifier": "D006224"}], [{"text": "adrenaline", "identifier": "H2152"}, {"text": "noradrenaline", "identifier": "H2151"}, {"text": "hypertension", "identifier": "D003827"}, {"text": "adrenaline-hypertension hypothesis", "identifier": "None"}, {"text": "double blind", "identifier": "D001021"}, {"text": "crossover study", "identifier": "D003835"}, {"text": "healthy volunteers", "identifier": "G029321"}, {"text": "infusions", "identifier": "D006228"}, {"text": "haemodynamic effects", "identifier": "D006228"}, {"text": "arterial pressure", "identifier": "D006511"}, {"text": "systolic arterial pressure", "identifier": "D0065"}], [{"text": "haloperidol", "identifier": "D006206"}, {"text": "cocaine", "identifier": "C002202"}, {"text": "amphetamine", "identifier": "C002205"}, {"text": "intoxication", "identifier": "D004111"}, {"text": "amphetamine", "identifier": "C002205"}, {"text": "cocaine", "identifier": "C002202"}, {"text": "seizures", "identifier": "D011111"}, {"text": "high doses", "identifier": "D011111"}, {"text": "mortality rate", "identifier": "D011111"}, {"text": "statistical significance", "identifier": "D011022"}, {"text": "central dopamine blocker", "identifier": "D010"}], [{"text": "Vasoactive intestinal polypeptide (VIP)", "identifier": "A060227"}, {"text": "heart failure", "identifier": "D001122"}, {"text": "cobalt cardiomyopathy", "identifier": "D011113"}, {"text": "doxorubicin", "identifier": "D012162"}, {"text": "ventricular muscle", "identifier": "D006593"}, {"text": "left ventricular muscle", "identifier": "D006593"}, {"text": "papillary muscles", "identifier": "D006593"}, {"text": "rheumatic disease", "identifier": "D006531"}, {"text": "myxomatous degeneration", "identifier": "D006531"}], [{"text": "Cocaine", "identifier": "D011012"}, {"text": "ethanol", "identifier": "C002635"}, {"text": "cocaethylene", "identifier": "None"}, {"text": "cardiotoxicity", "identifier": "D006537"}, {"text": "cocaine", "identifier": "D011012"}, {"text": "ethanol", "identifier": "C002635"}, {"text": "cocaethylene", "identifier": "None"}, {"text": "animal model", "identifier": "D010230"}, {"text": "abuse", "identifier": "D006211"}, {"text": "cardiovascular collapse", "identifier": "D009111"}, {"text": "hemodynamic changes", "identifier": "D006537"}], [{"text": "D-Glucarates", "identifier": "C076513"}, {"text": "renal damage", "identifier": "D006515"}, {"text": "aminoglycoside antibiotics", "identifier": "D012722"}, {"text": "dextran", "identifier": "D011133"}, {"text": "kanamycin", "identifier": "D011131"}, {"text": "peptide antibiotics", "identifier": "D011133"}, {"text": "renal failure", "identifier": "D006515"}, {"text": "2,5-di-O-acetyl-D-glucaro-1,4-6,3-dilactone", "identifier": "None"}, {"text": "saccharic acid", "identifier": "C063211"}], [{"text": "Flecainide", "identifier": "D006585"}, {"text": "delirium", "identifier": "D009011"}, {"text": "paroxetine", "identifier": "D011111"}, {"text": "pharmacokinetic drug interaction", "identifier": "D006565"}, {"text": "carvedilol", "identifier": "D006512"}, {"text": "warfarin", "identifier": "D006354"}, {"text": "folic acid", "identifier": "D003683"}, {"text": "levothyroxine", "identifier": "D006551"}, {"text": "pantoprazole", "identifier": "D007122"}, {"text": "atrial fibrillation", "identifier": "D001102"}], [{"text": "phase 2 early afterdepolarization (EAD)", "identifier": "D011113"}, {"text": "polymorphic ventricular tachycardia", "identifier": "D011113"}, {"text": "torsade de pointes (TdP)", "identifier": "D011113"}, {"text": "long-QT syndrome", "identifier": "D006511"}, {"text": "dl-sotalol", "identifier": "D011113"}, {"text": "azimilide", "identifier": "D011113"}, {"text": "transmural dispersion of repolarization (TDR)", "identifier": "D011113"}, {"text": "QT prolongation", "identifier": "D011113"}, {"text": "transmembrane action potentials", "identifier": "D00"}], [{"text": "tacrolimus", "identifier": "D011111 (FK506, Prograf)"}, {"text": "FK506", "identifier": "D011111"}, {"text": "bilateral optic neuropathy", "identifier": "D006211"}, {"text": "patient", "identifier": "D003630"}, {"text": "liver transplantation", "identifier": "D006552"}, {"text": "orthotropic liver transplantation", "identifier": "D006552"}, {"text": "neuro-ophthalmologic examinations", "identifier": "D006211"}, {"text": "laboratory studies", "identifier": "D003480"}, {"text": "ischemic optic neuropathies", "identifier": "D006211"}], [{"text": "Tranexamic acid", "identifier": "D011111"}, {"text": "overdosage", "identifier": "D411325"}, {"text": "generalized seizure", "identifier": "D009346"}, {"text": "renal failure", "identifier": "D006525"}, {"text": "chronic kidney disease", "identifier": "D006541"}, {"text": "chronic tubulointerstitial disease", "identifier": "D011133"}, {"text": "hemorrhagia", "identifier": "D001011"}, {"text": "menorrhagia", "identifier": "D001011"}, {"text": "packed cells", "identifier": "D012648"}, {"text": "hemodialysis", "identifier": "D002828"}]]}
